Prescription for Wellness: Extending Our Health Span

Current Aging Landscape and Key Challenges

• Lifespan vs. Health Span: While life expectancy has increased significantly over the last century (adding ~20 years in the US/Canada over 60 years), health span has not improved at the same rate, creating a "disability span" where older adults live longer with chronic disease.
• Disability Statistics: Women live approximately five years longer than men but spend at least half of that time in a state of disability, compared to men.
• Alzheimer's Paradox: Although the incidence rate of Alzheimer's at any specific age has declined over the last few decades, the total number of cases is rising alarmingly due to increased longevity.
• Untreated Chronic Conditions: In the US, 67 million people have hypertension; of these, 36 million have uncontrolled blood pressure and 14 million are unaware they are affected.
• Global Disparity: Latin American countries (e.g., Chile) are aging faster than Europe or the US, with life expectancy increasing by 20 years in just 19 years in Chile, creating a rapid societal adjustment burden.
• Prevention Funding Gap: The US federal health budget allocates only approximately 3.5% to prevention and wellness, despite these measures being the most effective means to reduce chronic disease.

Scientific Innovations and Biomedical Advances

• Biomedical Impact: From 2000 to 2009, 73% of gains in life expectancy were attributed directly to biomedical research and innovation.
• Future Biomedicine: Panelists foresee a "platinum age" of science in the next decade, potentially delivering unanticipated breakthroughs in disease mechanisms.
• Vaccine Potential: There is growing enthusiasm for developing vaccines for non-communicable diseases, including targeted interventions for obesity and specific cancer types.
• Longitudinal Research: The Canadian Longitudinal Study on Aging is currently tracking 50,000 participants (aged 45–65 at entry) for 20 years to stratify aging trajectories and understand the synergy of genomics, epigenomics, and microbiota.
• Drug Development: The "Dutch old" (metformin) study is being prepared to investigate delaying aging, though current pharmaceutical models struggle to monetize off-patent generic drugs.
• Genomic Precision: Personalized aging initiatives (e.g., USC's $99 genomic screening) use SNP markers to identify individual risks for Alzheimer's, diabetes, and cancer to tailor prevention programs.
• Gender Differences: Research gaps regarding sex differences are being addressed; for example, 70% of Alzheimer's patients are women, and a new global consortium is mandating the inclusion of female subjects in studies to better understand cognitive decline.

Economic Implications and Cost Projections

• Alzheimer's Costs: The annual cost of dementia care in the US is currently $250 billion; if current trends continue, costs could approach $1 trillion annually within two decades.
• Prevention ROI: Delaying the onset of Alzheimer's by an average of five years could save the US half a trillion dollars annually.
• Corporate Savings: Safeway reduced workforce obesity rates by 25% in eight years through wellness programs, resulting in increased productivity, loyalty, and reduced absenteeism.
• Healthcare System Limitations: The current "sick care" system focuses on treatment rather than prevention, with a fragmented payment model that disconnects patients from the true costs of care.
• Insurance Incentives: Life insurance companies are pioneering market-based incentives, offering premium discounts to policyholders who meet fitness goals (e.g., 20,000 daily steps) tracked via wearables.

Societal, Policy, and Behavioral Barriers

• Behavioral Disconnect: Knowledge alone is insufficient; the failure to act on health advice is attributed to a lack of personal motivation, introspection, and tangible incentives rather than a lack of information.
• Social Determinants: Health outcomes are heavily influenced by environmental factors such as safe streets, access to clean water, and proximity to healthy food, which are not universally available.
• Policy Momentum: The 2013 G8 Call for Action on Brain Health led to 80 countries signing a commitment, resulting in increased funding (e.g., Canada's $35 million investment) and collaborative frameworks for neurodegeneration research.
• Employer Role: Employers are identified as key leverage points for preventing chronic disease through cafeteria regulations, physical activity mandates, and healthy aging policies.
• Urban Planning: Over 80% of adults over 50 wish to age in place within existing cities, yet infrastructure often lacks the walkability and connectivity required to support this preference.
• Early Life Intervention: Aging processes begin before birth; preventing repetitive minor traumatic brain injuries (e.g., in youth sports) is critical to preserving cognitive reserve later in life.
• Transparency Issues: The disconnect between patients, providers, and costs (negotiated rates, fragmented billing) hinders the formation of effective patient-provider partnerships and personal accountability.